Rodent ischemic stroke models and their relevance in preclinical research
Neuroprotection · 2024-12 · 2 (4) · 296-309
DOI: 10.1002/nep3.62 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Neuroprotection, online erschienen am 04.11.2024. Verfasst von Maria Thaysen und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacy, Faculty of Health and Medical Sciences University of Copenhagen Copenhagen Denmark. Die Arbeit wurde bisher 22-mal zitiert (Crossref) und nennt 150 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Themen: Schlaganfall
Abstract (Originalsprache)
Stroke is a leading cause of death and disability worldwide, with ischemic stroke caused by an occluded vessel accounting for the majority of cases. Current treatments are limited to recanalization, either through thrombectomy or thrombolysis. Approved pharmacological interventions to suppress stroke‐associated excitotoxicity and neuroinflammatory events, leading to brain tissue death, are still lacking. Although numerous preclinical studies have been performed, they have yet to be translated into clinically relevant interventions. First‐line preclinical in vivo studies include the use of rodent ischemic stroke models, which vary in terms of how well they replicate human stroke pathophysiology and phenotype (including the formation of blood clot, blood–brain barrier disruption, neuroinflammation, and edema generation). Thus, rodent ischemic stroke models must be carefully chosen according to the specific pharmacological intervention to be tested. In this review, we aimed to provide an overview of the five most commonly used rodent ischemic stroke models and critically assess their advantages and limitations, with a primary focus on the acute phases of stroke.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Pharmacy, Faculty of Health and Medical Sciences University of Copenhagen Copenhagen Denmark.
- Department of Drug Design and Pharmacology, Faculty of Health and Medical Sciences University of Copenhagen Copenhagen Denmark.
- REGENBIO Consultants Limited Dunedin New Zealand.
ORCID-Profile: Mie Kristensen
Zitieren
APA
Thaysen, M., Westi, E., Clarkson, A. N., Wellendorph, P., & Kristensen, M. (2024). Rodent ischemic stroke models and their relevance in preclinical research. Neuroprotection, 2(4), 296-309. https://doi.org/10.1002/nep3.62
Vancouver
Thaysen M, Westi E, Clarkson AN, Wellendorph P, Kristensen M. Rodent ischemic stroke models and their relevance in preclinical research. Neuroprotection. 2024;2(4):296-309. doi:10.1002/nep3.62
BibTeX
@article{Thaysen2024,
author = {Thaysen, Maria and Westi, Emil and Clarkson, Andrew N and Wellendorph, Petrine and Kristensen, Mie},
title = {Rodent ischemic stroke models and their relevance in preclinical research},
journal = {Neuroprotection},
year = {2024},
volume = {2},
number = {4},
pages = {296--309},
doi = {10.1002/nep3.62}
}
EUVIMED